Starting 2025 With A Bolt-On Deal For Inari Medical
Stryker inks $4.9B deal for blood clot buster Inari Medical
After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening its pocketbook a bit wider to acquire Inari Medical, with it | Stryker said the addition of Inari’s devices for venous thromboembolism will complement its current neurovascular business.
Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...
Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic ...
Inari is chiefly known for making peripheral vascular devices, including catheters and thrombectomy systems. The company is perhaps best known for FlowTriever, the first mechanical thrombectomy ...
Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...
With this new partnership, Inari plans to accelerate initiation ... including vascular access devices such as hemodialysis catheters, intravenous catheters, sheaths, and guiding catheters.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback